News | December 13, 2010

Women may be Less Likely to Accept Physician’s Heart Treatment Recommendation

December 13, 2010 - One possible explanation for disparities in care for acute coronary syndrome between men and women may be that women are less likely to accept their physician’s recommendation on treatment. The results of the study were reported online today in Annals of Emergency Medicine.

“The well-documented ‘Mars and Venus’ differences between the sexes may play out in how patients make medical decisions,” said lead study author Judd Hollander, M.D., of the department of emergency medicine at the University of Pennsylvania. “Prior studies of coronary patients have attributed disparities in care between men and women to access problems, differences in insurance coverage or physician biases. Our study shows that at least part of the previously noted gender disparity can be explained by patient preferences.”

Researchers enrolled 1,080 patients who came to the emergency department with symptoms of acute coronary syndrome. Women and men both preferred stress testing to cardiac catheterization, and both sexes accepted their physician’s recommendation for stress testing equally (85 percent for both sexes). However, only 65 percent of women stated that they would accept cardiac catheterization, compared to 75 percent of men. And only 67 percent of women said they would accept their physician’s recommendation for angioplasty, versus 73 percent of men. Women were less likely to desire coronary artery bypass grafting than men (61 percent versus 68 percent).

Of patients enrolled in the study who were admitted to the hospital (60 percent of the total), 38 percent of women received diagnostic testing of any kind, versus 45 percent of men. And 10 percent of women received cardiac catheterization, versus 17 percent of men.

Researchers theorized that women might be less willing to undergo diagnostic testing and treatment because they perceive their disease as less severe, or because they have lower tolerance for the risks associated with such procedures.

“The challenge for health care providers is to make sure both men and women have all the information at their disposal to make the best decisions about their own medical care,” Hollander said. “Future studies should focus on identifying the reasons that women appear less likely than men to accept physician-recommended tests and treatments for acute coronary syndrome.”

For more information: www.acep.org


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now